| Literature DB >> 19011400 |
Rey P Vivo1, Selim R Krim, Joanne Perez, Mahakit Inklab, Thomas Tenner, John Hodgson.
Abstract
Heralded as the oldest known cardiovascular drug, digoxin remains widely used today in the face of increasing rates in heart failure and atrial fibrillation despite the emergence of newer medications. Its hemodynamic, neurohormonal and electrophysiologic actions make it a suitable adjunctive, evidence-based therapy for the above conditions. Its narrow therapeutic index and its toxicity, however, have become more relevant as aging, comorbid diseases, and polypharmacy make more patients vulnerable. Because signs and symptoms of digoxin toxicity are mostly nonspecific, a high index of suspicion is crucial for early recognition and appropriate management.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19011400 DOI: 10.1097/MAJ.0b013e318176b94d
Source DB: PubMed Journal: Am J Med Sci ISSN: 0002-9629 Impact factor: 2.378